Single‐cell level characterization of B cell depletion and repopulation following rituximab in systemic lupus erythematosus
Objective Rituximab, a CD20 + B cell depletion therapy, is frequently used to treat systemic lupus erythematosus (SLE). However, variability in patient response highlights the need for a deeper understanding of the underlying immune cell dynamics of B cell depletion and repopula…